Who owns BIOAFFINITY TECHNOLOGIES INC?
- Ticker: BIAF
- CUSIP Number: 09076w307
Tip: Access positions for across all investors
Analyze quarterly positions in Bioaffinity Technologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioaffinity Technologies stock
Who bought or sold BIOAFFINITY TECHNOLOGIES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 366k | $297k | 100% | Jun 2026 |
|
| BlackRock | 99k | $80k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 56k | $45k | 0% | Jun 2026 |
|
| Geode Capital Management | 51k | $41k | 6% | Jun 2026 |
|
| J. Safra Sarasin Holding | 43k | $164k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 31k | $25k | 0% | Jun 2026 |
|
| Susquehanna International | 27k | $22k | 100% | Jun 2026 |
|
| Jane Street | 27k | $22k | 100% | Jun 2026 |
|
| Hrt Financial | 21k | $16k | 100% | Jun 2026 |
|
| Northern Trust | 17k | $14k | 32% | Jun 2026 |
|
| State Street Corporation | 14k | $55k | 100% | Mar 2026 |
|
| Virtu Financial | 11k | $9.0k | 100% | Jun 2026 |
|
| Parrish Capital | 10k | $8.5k | 100% | Jun 2026 |
|
| Hanson McClain Advisors | 10k | $8.1k | 100% | Jun 2026 |
|
| Tower Research Capital | 6.5k | $5.3k | 214% | Jun 2026 |
|
| UBS Group | 4.2k | $3.4k | -54% | Jun 2026 |
|
| EMC Capital Management | 2.0k | $1.0k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 931.00 | $999.987100 | 100% | Jun 2026 |
|
| IFP Advisors | 833.00 | $675.979500 | 0% | Jun 2026 |
|
| Citigroup | 57.00 | $218.002200 | 100% | Mar 2026 |
|
| Morgan Stanley | 3.00 | $11.000100 | 0% | Mar 2026 |
|
Who sold out of Bioaffinity Technologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Mar 2026 | 24k | $94k |
| Ameritas Advisory Services | Mar 2026 | 1.0k | $3.8k |